![A cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospital. - Abstract - Europe PMC A cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospital. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4178340/bin/NMJ-55-417-g002.jpg)
A cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospital. - Abstract - Europe PMC
![Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - ScienceDirect Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673606696669-gr4.gif)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - ScienceDirect
![Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta‑analysis of randomized, double‑blinded, controlled trials Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta‑analysis of randomized, double‑blinded, controlled trials](https://www.spandidos-publications.com/article_images/etm/19/4/etm-19-04-3031-g06.jpg)
Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta‑analysis of randomized, double‑blinded, controlled trials
![Effect of administration of ketorolac, etoricoxib or diclofenac in the... | Download Scientific Diagram Effect of administration of ketorolac, etoricoxib or diclofenac in the... | Download Scientific Diagram](https://www.researchgate.net/publication/51841156/figure/fig1/AS:667191997378569@1536082376663/Effect-of-administration-of-ketorolac-etoricoxib-or-diclofenac-in-the-pain-of-ankle.png)
Effect of administration of ketorolac, etoricoxib or diclofenac in the... | Download Scientific Diagram
![Pillole.org - Pillole: Etoricoxib e diclofenac presentano lo stesso rischio trombotico: studio MEDAL Pillole.org - Pillole: Etoricoxib e diclofenac presentano lo stesso rischio trombotico: studio MEDAL](http://www.pillole.org/public/aspnuke/downloads/immagini/medalmainresults.jpg)
Pillole.org - Pillole: Etoricoxib e diclofenac presentano lo stesso rischio trombotico: studio MEDAL
![Effects of multiple dosing of etoricoxib, diclofenac, or indomethacin... | Download Scientific Diagram Effects of multiple dosing of etoricoxib, diclofenac, or indomethacin... | Download Scientific Diagram](https://www.researchgate.net/publication/12168450/figure/fig2/AS:277473246892033@1443166185229/Effects-of-multiple-dosing-of-etoricoxib-diclofenac-or-indomethacin-on-gastrointestinal.png)
Effects of multiple dosing of etoricoxib, diclofenac, or indomethacin... | Download Scientific Diagram
![Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | Drug Safety Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | Drug Safety](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40264-022-01211-1/MediaObjects/40264_2022_1211_Fig1_HTML.png)
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | Drug Safety
Etoricoxib versus diclofenac for hypertension. CI, confidence interval. | Download Scientific Diagram
![COMPARATIVE EFFICACY OF COMBINED USE OF DICLOFENAC WITH THIOCOLCHICOSIDE AND DICLOFENAC ALONE IN ORTHOPEDIC PATIENTS | Semantic Scholar COMPARATIVE EFFICACY OF COMBINED USE OF DICLOFENAC WITH THIOCOLCHICOSIDE AND DICLOFENAC ALONE IN ORTHOPEDIC PATIENTS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ebc1f8e9d4687dabaca8f1ed4c929e03127fda3/2-Table1-1.png)
COMPARATIVE EFFICACY OF COMBINED USE OF DICLOFENAC WITH THIOCOLCHICOSIDE AND DICLOFENAC ALONE IN ORTHOPEDIC PATIENTS | Semantic Scholar
![PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/58842943eddcb944204ee81faa180de7be874471/6-Figure2-1.png)
PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar
![PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/58842943eddcb944204ee81faa180de7be874471/4-Table1-1.png)
PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar
![Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489] | BMC Musculoskeletal Disorders | Full Text Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489] | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1471-2474-6-58/MediaObjects/12891_2004_Article_171_Fig1_HTML.jpg)
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489] | BMC Musculoskeletal Disorders | Full Text
![Etoricoxib I.P. 10 mg, Methyl Salicylate I.P. 100MG, Menthol I.P. 50 mg, Linseed Oil B.P. 30mg Gel at Rs 135/piece | Sector 20 | Sas Nagar | ID: 12930231262 Etoricoxib I.P. 10 mg, Methyl Salicylate I.P. 100MG, Menthol I.P. 50 mg, Linseed Oil B.P. 30mg Gel at Rs 135/piece | Sector 20 | Sas Nagar | ID: 12930231262](https://5.imimg.com/data5/NI/GP/MY-9666337/diclofenac-linseed-oil-capsaicin-500x500.jpeg)
Etoricoxib I.P. 10 mg, Methyl Salicylate I.P. 100MG, Menthol I.P. 50 mg, Linseed Oil B.P. 30mg Gel at Rs 135/piece | Sector 20 | Sas Nagar | ID: 12930231262
![Lower Gastrointestinal Events in a Double-Blind Trial of the Cyclo-Oxygenase-2 Selective Inhibitor Etoricoxib and the Traditional Nonsteroidal Anti-Inflammatory Drug Diclofenac - ScienceDirect Lower Gastrointestinal Events in a Double-Blind Trial of the Cyclo-Oxygenase-2 Selective Inhibitor Etoricoxib and the Traditional Nonsteroidal Anti-Inflammatory Drug Diclofenac - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508508014078-gr1.jpg)
Lower Gastrointestinal Events in a Double-Blind Trial of the Cyclo-Oxygenase-2 Selective Inhibitor Etoricoxib and the Traditional Nonsteroidal Anti-Inflammatory Drug Diclofenac - ScienceDirect
![PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/58842943eddcb944204ee81faa180de7be874471/3-Figure1-1.png)
PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar
Effects of treatment with diclofenac or etoricoxib on gingival PGE2... | Download Scientific Diagram
![Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet](https://www.thelancet.com/cms/attachment/2000989387/2003643106/gr1.jpg)
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
![Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet](https://www.thelancet.com/cms/attachment/2000988127/2003634384/gr1.gif)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
![IJERPH | Free Full-Text | Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System IJERPH | Free Full-Text | Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System](https://pub.mdpi-res.com/ijerph/ijerph-19-03541/article_deploy/html/images/ijerph-19-03541-g001.png?1647498084)
IJERPH | Free Full-Text | Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System
![Figure 2 from Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study). | Semantic Scholar Figure 2 from Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/66bda4e09ce67d69c8ae630ca32c0d5d252506c1/5-Figure2-1.png)